» Authors » Charlotte Suppli Ulrik

Charlotte Suppli Ulrik

Explore the profile of Charlotte Suppli Ulrik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 218
Citations 2230
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hjortdahl F, Soendergaard M, Hansen S, Bjerrum A, von Bulow A, Hilberg O, et al.
Lung . 2025 Mar; 203(1):42. PMID: 40069448
Background: In severe asthma, intensive ("supratherapeutic") doses of inhaled corticosteroids (ICS) are often used. The prevalence of supratherapeutic ICS use and its impact on corticosteroid-related comorbidities is poorly understood. We...
2.
Dalboge A, Kolstad H, Jahn A, Ulrik C, Sherson D, Meyer H, et al.
Scand J Work Environ Health . 2025 Mar; PMID: 40062941
Objective: The aim of this systematic review was to identify, evaluate, and synthesize the relation between ten potential occupational sensitizing exposure groups and asthma. Methods: A systematic literature search was...
3.
Hansen A, Hakansson K, Mikkelsen A, Ali Z, Pinborg A, Lidegaard O, et al.
J Allergy Clin Immunol Pract . 2025 Mar; PMID: 40057188
Background: Asthma is common among women of reproductive age. Prior studies have revealed an association between asthma and fertility by reporting prolonged time to pregnancy and lower fecundability. Objective: Investigate...
4.
Hakansson K, Ibsen R, SteenKrogh N, Krogh N, BaastrupSoendergaard M, Soendergaard M, et al.
J Asthma . 2025 Feb; :1-11. PMID: 39997607
Introduction: Severe asthma impacts work capacity, but little is known about the effects of biologic therapy on patients' ability to work. We aimed to assess the impact of biologic therapy...
5.
Ottesen T, Rovsing A, Ulrik C
Respir Med . 2025 Feb; 238:107962. PMID: 39921068
Background And Aim: The pharmacological profile of ciclesonide suggests that it may be associated with fewer local and systemic adverse effects compared to other inhaled corticosteroids. The aim of this...
6.
Soendergaard M, Hjortdahl F, Hansen S, Bjerrum A, von Bulow A, Hilberg O, et al.
Eur Respir J . 2025 Jan; PMID: 39788633
Background: Biologics can induce remission in some patients with severe asthma, however, little is known about pre-biologic disease trajectories and their association with outcomes from biological treatment. We aimed to...
7.
Savran O, Bonnelykke K, Ulrik C
J Asthma Allergy . 2024 Dec; 17:1291-1300. PMID: 39698488
Background And Aim: Asthma in early life has been linked to subsequent development of COPD and according to GOLD 2023 COPD may be divided into distinct subtypes. We aimed to...
8.
Soendergaard M, Hansen S, Hakansson K, von Bulow A, Bjerrum A, Schmid J, et al.
Allergy . 2024 Dec; PMID: 39673455
Background: In patients with severe asthma, treatment with anti-interleukin-5 (IL-5) biologics can lead to a reduction in fractional exhaled nitric oxide (FeNO) in some patients. The clinical implications of varying...
9.
Andreasson K, Jacobsen J, Leth Egsgaard A, Rauff Denby K, Hyldgaard C, Bodtger U, et al.
Eur Clin Respir J . 2024 Nov; 11(1):2413318. PMID: 39529704
Background And Purpose: Dysfunctional breathing (DB) with or without an underlying medical condition is associated with impaired quality of life. DB-related symptoms can be measured with the 25-item Self Evaluation...
10.
Savran O, Bonnelykke K, Ulrik C
Eur Clin Respir J . 2024 Oct; 11(1):2413199. PMID: 39380916
Background And Objective: Our knowledge of socioeconomic status (SES) and emergency department (ED) visits in adults with a history of severe childhood asthma is limited. Our aim was, therefore, to...